Jeena Sikho Lifecare Jeena Sikho Lifecare expanded its healthcare portfolio on July 27, 2026, by launching four new Ayurvedic pain relief products. The launch strengthens the company’s range of external application solutions, adding specialized patches for back and knee pain alongside general-purpose variants. This move broadens the company’s domestic market offerings within the scientific Ayurveda segment.

The company disclosed the product launches under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was submitted to both the National Stock Exchange of India Limited and BSE Limited. The disclosure aligns with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, and Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Product Portfolio Expansion

The newly launched products cater exclusively to the domestic market. Each variant is designed for specific body areas or general use, featuring natural herbal formulas as highlighted in their packaging. The products are recommended by Acharya Manish Ji, as indicated on the packaging materials.

Regulatory Compliance

Manish Grover, Managing Director of Jeena Sikho Lifecare Limited (DIN: 07557886), signed the disclosure from the company’s registered office in Zirakpur, Punjab. The detailed particulars for each product were provided in Annexures A to D attached to the exchange filings. The company confirmed that this information is also available on its official website, www.jeenasikho.com .

The expansion adds to the company’s existing presence across 120+ Ayurveda clinics and hospitals. The new SKUs allow the company to address specific pain points such as back flexibility and joint mobility with targeted formulations.

Jeena Sikho Lifecare Limited is expanding its operational infrastructure by establishing a new Client Support Centre at A-33, Sector-136, Noida, Uttar Pradesh. The move aims to strengthen customer engagement capabilities by centralizing support functions, including patient assistance, appointment scheduling, enquiry management, and tele-counselling. This expansion supports the company’s broader strategy to enhance service efficiency as it scales its network of Ayurveda clinics and hospitals.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III, and SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. Manish Grover, Managing Director, signed the filing on July 25, 2026, submitting the details to the National Stock Exchange of India Limited and BSE Limited.

The proposed facility spans an estimated area of approximately 17,700 sq. ft. and is designed to accommodate a seating capacity of approximately 300 customer support executives. The centre will serve as a dedicated hub for allied operational activities, allowing the company to streamline its customer interaction processes.

The total investment required for the project is approximately ₹2.37 crore, which will be financed entirely through internal accruals. This capital allocation reflects the company’s reliance on self-generated funds for this specific infrastructure upgrade, avoiding external debt or equity dilution for this initiative.

Operational Timeline and Rationale

The company expects the Client Support Centre Facility to become operational within 45 to 60 days from the execution of the Lease Agreement. This timeline is subject to the completion of fit-out works, installation of IT infrastructure, and other necessary operational requirements.

According to the filing, the rationale behind this expansion is to improve customer service capabilities and support future business expansion. By consolidating these functions into a dedicated facility, Jeena Sikho Lifecare Limited intends to enhance operational efficiency across its customer touchpoints.

What the Numbers Show

The decision to fund the ₹2.37 crore expansion through internal accruals indicates strong cash flow generation relative to this specific capex requirement. With a capacity for 300 executives in a 17,700 sq. ft. space, the company is prioritizing high-density operational setups to maximize utility per square foot. The rapid 45-to-60-day rollout timeline suggests that the site may already be identified or pre-vetted, minimizing lead time for implementation.